3rd Annual Global Medical Affairs Summit

In the world of constant changes the role of medical affairs is becoming increasingly important, especially under COVID-19 pressure. With the constant development in technology the strategies and decision-making tools as well as challenges are transformed into new units. How do medical affairs handle changing demands? What are the best ways to integrate the e-medical tactics? How do companies deal with the proliferation of data and demands for transparency? Join us at our interactive medical event to have your questions answered!

The 3rd Annual Global Medical Affairs Summit has been designed to provide a complex understanding of trends, innovations, challenges, recommendations and insights vital for successful performance of medical affairs in 2021.  Senior-level experts from top pharma companies will get together at this summit to share their views on the future perspectives for MA, new product launching during COVID-19, secret tool to be used by MA professionals, collaboration between two pharma companies and WHO and much more.   

This event will provide you with lessons learned and valuable tips shared by top minds involved in medical affairs. You will also benefit from remarkable networking opportunities due to limited seats of this business event. It is the right place for sharing the ideas, getting insights and inspiration, learning from experienced leaders and establishing important business contacts!

Join us and register today

Stay on top of the latest trends

Key speakers

Rafael <br><b> BRAVO</b>


Vice President Obesity, RWE & Publications in Global Medical Affairs
Benedikte <br><b> THUNES AKRE</b>


Medical Affairs Director, Oncology & Hematology, Nordics
Inaam <br><b>HAQ</b>


Medical Director
Alex <br><b>MEHUYS</b>


Medical Director EMEA Hematology
Gareth <br><b>WORTHINGTON</b>


Director, Global Scientific Content, Oncology Team Lead
Jolana <br><b>SCHMIEDL</b>


Associate Director Medical Affairs

Key topics

  • How do the new EU MedTechs impact medical affairs?
  • What are the best ways to integrate the e-medical tactics in medical affairs?
  • What are the innovative ways of mining and interpreting data?
  • The RWE as main decision-making instrument in drug development and commercialisation
  • How is COVID-19 affecting the activity of MSLs in companies: Ways of adaptation?
  • Medical affairs as a key instrument in bridging the gap between R&D and Commercial
  • Collaboration between medical affairs and tech innovators as a way to improve engagement with patients (by using innovative products and technologies)

Who Should Attend

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, and Heads of departments from pharma industry involved in:

  • Medical Science Liaisons (MSL)
  • Medical Information
  • Medical Writing
  • Medical and Scientific Communication
  • Scientific Affairs
  • Real World Evidence
  • Commercial Excellence
  • Market Access
  • KOL/Thought Leader Relations/Engagement
  • Clinical Affairs
  • Medical Review
  • Health Economics and Outcomes Research/HEOR
  • Product Launch
  • Patient Outcome
  • Patient Centricity
  • Digital Medical
  • Customer Value
  • Scientific Engagement
  • Scientific Partnerships
  • Commercial Operations
  • External Affairs
  • Medical Affairs Operations
  • Medical Strategy
  • Policy & Market Access
  • Portfolio Planning
  • Launch Management
  • Medical/Scientific/Patient Communications
  • Scientific Information